– Endece Neural LLC on Friday said it has received a $225,000
grant from the National Multiple Sclerosis Society to continue
its work on a multiple sclerosis treatment.
The grant money
will help Endece continue to develop its lead compound, which
the company says could improve the lives of multiple sclerosis
patients, according to a company statement.
immune systems attack the myelin coating that protects the
brain’s nerve cells. The damage disrupts the ability of parts of
the nervous system to communicate.
available therapies for MS are designed to slow the progression
of the disease by reducing inflammation, but do not activate key
target cells that can manufacture myelin," said Steven H. Ney,
vice president of discovery at Endece Neural.
"We are pleased
to partner with innovators like Endece Neural to enable
continued development of their therapeutic programs," said
Timoth Coetzee, chief research officer at the National MS